Article info

Download PDFPDF
Extended report
Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis

Authors

  1. Correspondence to Lieve Van Hoovels, Department of Laboratory Medicine, Onze-Lieve Vrouw Hospital, Moorselbaan 164, Aalst 9300, Belgium; lieve.Van.Hoovels{at}olvz-aalst.be
View Full Text

Citation

Van Hoovels L, Jacobs J, Vander Cruyssen B, et al
Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis

Publication history

  • Received September 10, 2017
  • Revised November 7, 2017
  • Accepted November 28, 2017
  • First published January 23, 2018.
Online issue publication 
April 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.